Stay updated on TQ05105 Tablets in Refractory aGVHD Clinical Trial
Sign up to get notified when there's something new on the TQ05105 Tablets in Refractory aGVHD Clinical Trial page.

Latest updates to the TQ05105 Tablets in Refractory aGVHD Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedNo significant changes detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedRemoved the government funding notice that warned about possible delays and directed users to cc.nih.gov and opm.gov. The banner was a non-core site-wide alert rather than part of the trial data or study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check34 days agoChange DetectedRecord History shows updates to Study Status and Recruitment Status across versions. These updates reflect changes in the trial's current state and enrollment status.SummaryDifference0.1%

- Check63 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference13%

- Check70 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive changes.SummaryDifference0.3%

- Check85 days agoChange Detected- Revision updated from v3.0.1 to v3.0.2; no other substantive content changes are evident. - The 'Back to Top' control was removed.SummaryDifference0.8%

Stay in the know with updates to TQ05105 Tablets in Refractory aGVHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TQ05105 Tablets in Refractory aGVHD Clinical Trial page.